The future of neuroprotection.
Slikkker
W
W
Division of Neurotoxicology, National Center for Toxicological Research/FDA, Jefferson, Arkansas 72079-9502, USA. wslikker@nctr.fda.gov
Youdim
M
M
Palmer
G C
GC
Hall
E
E
Williams
C
C
Trembly
B
B
D000818:Animals; D001930:Brain Injuries / Q000378:metabolism / Q000628:therapy; D004359:Drug Therapy, Combination; D005544:Forecasting; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy; D017382:Reactive Oxygen Species / Q000378:metabolism; D020521:Stroke / Q000188:drug therapy
D018696:Neuroprotective Agents; D017382:Reactive Oxygen Species